Ligand validation:7BVR

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7BVR_EPE_B_202	33%	31%	0.26	0.939	0.87	1.84	1	5	0	0	100%	1
7BVR_EPE_F_201	27%	29%	0.299	0.948	0.84	1.99	1	6	0	0	100%	1
7BVR_EPE_H_201	27%	28%	0.304	0.953	0.8	2.04	1	5	0	0	100%	1
7BVR_EPE_D_201	20%	30%	0.341	0.944	0.82	1.96	1	6	0	0	100%	1
7BVR_EPE_B_201	9%	30%	0.412	0.901	0.81	1.97	1	6	2	0	100%	1
7EXZ_EPE_B_202	41%	25%	0.236	0.954	0.79	2.24	1	5	0	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	44%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	15%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	31%	0.063	0.987	0.79	1.91	1	5	1	0	100%	1
4WYD_EPE_B_503	98%	44%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.